Discussion about this post

User's avatar
Ollie Darby's avatar

Love that the open source models had already reached every top 20 pharma company before the seed round, that's about as clear a signal of pull as you get and way more convincing than any deck. And when you see results like the UCSF team clearing an aggressive childhood brain cancer in mice this week you realise how much of the game is getting good candidates to trials faster, so anything that cuts the dud experiments early feels like a really big deal.

Ready for more?